The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation

被引:7
作者
von Muecke-Heim, Iven-Alex [1 ]
Martin, Jana [1 ]
Uhr, Manfred [2 ]
Ries, Clemens [1 ]
Deussing, Jan M. M. [1 ]
机构
[1] Max Planck Inst Psychiat, Mol Neurogenet, Munich, Germany
[2] Max Planck Inst Psychiat, Core Unit Analyt & Mass Spectrometry, Munich, Germany
关键词
mouse model; cell culture; immunomodulation; knockout (KO) mice; microglia; cytokine secretion; MAJOR DEPRESSIVE DISORDER; PSYCHOLOGICAL STRESS; P2X(7) RECEPTOR; INFLAMMATION; METAANALYSIS; ASSOCIATION; ADENOSINE; RELEASE; CELLS;
D O I
10.3389/fphar.2023.1148190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: In recent years, purinergic signaling via the P2X7 receptor (P2X7R) on microglia has repeatedly been implicated in depression genesis. However, it remains unclear which role the human P2X7R (hP2X7R) plays in regulating both microglia morphology and cytokine secretion upon different environmental and immune stimuli, respectively. Methods: For this purpose, we used primary microglial cultures derived from a humanized microglia-specific conditional P2X7R knockout mouse line to emulate different gene-environment interactions between microglial hP2X7R and molecular proxies of psychosocial and pathogen-derived immune stimuli. Microglial cultures were subjected to treatments with the agonists 2'(3')-O-(4-benzoylbenzoyl)-ATP (BzATP) and lipopolysaccharides (LPS) combined with specific P2X7R antagonists (JNJ-47965567, A-804598). Results: Morphotyping revealed overall high baseline activation due to the in vitro conditions. Both BzATP and LPS + BzATP treatment increased round/ameboid microglia and decreased polarized and ramified morphotypes. This effect was stronger in hP2X7R-proficient (CTRL) compared to knockout (KO) microglia. Aptly, we found antagonism with JNJ-4796556 and A-804598 to reduce round/ameboid microglia and increase complex morphologies only in CTRL but not KO microglia. Single cell shape descriptor analysis confirmed the morphotyping results. Compared to KO microglia, hP2X7R-targeted stimulation in CTRLs led to a more pronounced increase in microglial roundness and circularity along with an overall higher decrease in aspect ratio and shape complexity. JNJ-4796556 and A-804598, on the other hand, led to opposite dynamics. In KO microglia, similar trends were observed, yet the magnitude of responses was much smaller. Parallel assessment of 10 cytokines demonstrated the proinflammatory properties of hP2X7R. Following LPS + BzATP stimulation, IL-1 beta, IL-6, and TNFa levels were found to be higher and IL-4 levels lower in CTRL than in KO cultures. Vice versa, hP2X7R antagonists reduced proinflammatory cytokine levels and increased IL-4 secretion. Discussion: Taken together, our results help disentangle the complex function of microglial hP2X7R downstream of various immune stimuli. In addition, this is the first study in a humanized, microglia-specific in vitro model identifying a so far unknown potential link between microglial hP2X7R function and IL-27 levels.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells
    Asatryan, Liana
    Ostrovskaya, Olga
    Lieu, Dustin
    Davies, Daryl L.
    NEUROPHARMACOLOGY, 2018, 128 : 11 - 21
  • [22] The roles of P2X7 receptor in regional-specific microglial responses in the rat brain following status epilepticus
    Hea Kyung Choi
    Hea Jin Ryu
    Ji-Eun Kim
    Seung-Mook Jo
    Hui-Chul Choi
    Hong-Ki Song
    Tae-Cheon Kang
    Neurological Sciences, 2012, 33 : 515 - 525
  • [23] The P2X7 receptor: A main player in inflammation
    Adinolfi, Elena
    Giuliani, Anna Lisa
    De Marchi, Elena
    Pegoraro, Anna
    Orioli, Elisa
    Di Virgilio, Francesco
    BIOCHEMICAL PHARMACOLOGY, 2018, 151 : 234 - 244
  • [24] Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates
    Ory, Dieter
    Celen, Sofie
    Gijsbers, Rik
    Van Den Haute, Chris
    Postnov, Andrey
    Koole, Michel
    Vandeputte, Caroline
    Andres, Jose-Ignacio
    Alcazar, Jesus
    De Angelis, Med
    Langlois, Xavier
    Bhattacharya, Anindya
    Schmidt, Mark
    Letavic, Michael A.
    Vanduffel, Wim
    Van Laere, Koen
    Verbruggen, Alfons
    Debyser, Zeger
    Bormans, Guy
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (09) : 1436 - 1441
  • [25] Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism
    McInnes, I. B.
    Cruwys, S.
    Bowers, K.
    Braddock, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 878 - 882
  • [26] P2X7 purinergic receptor: A potential target in heart diseases (Review)
    Dayel, Anfal Bin F.
    Alonazi, Asma S.
    Alshammari, Tahani K.
    Alrasheed, Nouf M.
    MOLECULAR MEDICINE REPORTS, 2023, 27 (03)
  • [27] Ethanol upregulates the P2X7 purinergic receptor in human macrophages
    Le Dare, Brendan
    Victoni, Tatiana
    Bodin, Aude
    Vlach, Manuel
    Vene, Elise
    Loyer, Pascal
    Lagente, Vincent
    Gicquel, Thomas
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (01) : 63 - 74
  • [28] The P2X7 purinergic receptor in intervertebral disc degeneration
    Penolazzi, Letizia
    Bergamin, Leticia S.
    Lambertini, Elisabetta
    Poma, Valentina V.
    Sarti, Alba C.
    De Bonis, Pasquale
    Di Virgilio, Francesco
    Piva, Roberta
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (02) : 1418 - 1428
  • [29] P2X7 Receptor as a Therapeutic Target
    De Marchi, Elena
    Orioli, Elisa
    Dal Ben, Diego
    Adinolfi, Elena
    ION CHANNELS AS THERAPEUTIC TARGETS, PT B, 2016, 104 : 39 - 79
  • [30] Novel P2X7 receptor antagonists ease the pain
    King, B. F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) : 565 - 567